LAB & PROTEOMIC TEC
Mutshidzi Ramovha, with a BSc in Biochemistry and Microbiology, brings diverse experience to her work. As an AIME mentor for two...
Hishaam completed his National Diploma in Biotechnology at CPUT in 2022. Afterwards he then went on to do his internship at a food testing...
Liam completed his post-graduate studies in Prof. Jonathan Blackburn’s lab in 2013 focused on PBMC phenotyping of TB-IRIS...
Jonathan is the South African Research Chair in Applied Proteomics & Chemical Biology; a Full Member & Deputy Director...
Tim is the DIPLOMICS program manager, which means that he is responsible for delivering on the objectives of the program, and...
To become a world class facility that will improve access to, and uptake of, the use of molecular phenotyping to help unlock value in your science.
To create a core facility that will empower utilisation of technology platforms in the discovery, validation and application of molecular phenotypes in everyday research questions from precision medicine to agriculture.
Our Origin Story
The Department of Science and Innovation (DSI) embarked on a focused program for infrastructure capacitation in certain key areas in the South African Science and Innovation space in 2017. This program was called the South African Research Infrastructure Roadmap (SARIR) and one of the main programs (of 9 in total) is DIPLOMICS which has enabled the formation of the D-CYPHR hub through engagement with some of it’s network labs, notably the CPGR and IDM Core facility.
Separately the DSI funds the Technology Innovation Agency (TIA) whose remit is to help create technology platforms to facilitate the bioeconomy in SA. The CPGR, founded in 2007, has received funding from TIA to facilitate the creation of a service platform focusing on both proteomic and genomic needs within the country.
Through DIPLOMICS and it’s network labs that it supports, the CPGR and IDM core facility the D-CYPHR hub was formed based on equipment from these entities in January 2022.
We offer the analyse of proteins and/or metabolites using a Discovery and Targeted Proteomics approach.